Trial Details

COMPLETED
Basic Information
Clinical ID c1059
Identifier NCT02958865
Trial Title Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: PF-06651600 or Placebo|DRUG: PF-06700841 or Placebo|DRUG: PF-06700841|DRUG: PF-06651600
Participant Information
Sponsor Pfizer
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2017-02-03
Primary Completion Date 2021-05-10
Completion Date 2021-05-10